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Abstract
Three alkaloids, lycorine, homolycorine and 2-O-acetyllycorine, 
were isolated from the bulbs of Leucojum vernum (Amaryllida­
ceae) and identified by means of NMR analysis. The alkaloids ob­
tained from L. vernum and from other Amaryllidaceae species 
were studied in vitro for HIV-1 replication inhibitory activity on 
MT4 cells. The cytotoxicity of the compounds in uninfected cells 
was evaluated by using the MTT assay and the [3H]thymidine in­
corporation test. The antiviral activities were determined by 
means of the p24 antigen assay and solid-phase reverse tran­
scriptase testing. The results demonstrate that trisphaeridine, ly- 
corine, homolycorine, and haemanthamine possess high antire­
troviral activities (IC50 = 0.4-7.3 pg/mL), accompanied by low 
therapeutic indices (TI50 = 1.3 -1.9).
lycorine [7], [8], [9]. Its 1H-NMR and JMOD spectra indicated that 
compound 3 was a monoacetyl derivative of lycorine. All carbon 
and proton signals were assigned through 1H-1H COSY, HSQC and 
HMBC experiments. The 1H -1H COSY spectrum demonstrated 
an -CH-CH-CH(OH)-CH(OAc)-CH = (C-11c-C-11b-C-1-C-2-C-3) 
structural fragment in the molecule (correlative signals between 
Ő  = 2.80/2.71, 2.71/4.52, 4.52/5.32 and 5.32/5.47), indicating 
the structure 2-O-acetyllycorine (3). This compound was pre­
viously isolated from Hippeastrum aulicum var. robustum, and 
also prepared as a semisynthetic derivative [10], [11]. As a result 
of extensive NMR studies previously unpublished 1H and 13C che­
mical shift assignments can now be reported.
The Amaryllidaceae species have provided many new promising 
antiviral alkaloids. Narciclasine, pancratistatine and lycorine 
have been found to exert pronounced inhibitory effects against 
Flaviviruses and Bunyaviruses [1]. Lycorine, the most intensively 
investigated compound of this group, displayed strong antiviral 
effects against poliovirus, Coxsackie, Semliki forest, measles and 
Herpes simplex type I viruses [2], [3], and pretazettine proved ac­
tive against various oncogenic viruses [4]. Moreover, the DNA- 
and RNA-binding activities of Amaryllidaceae alkaloids have 
also been confirmed, suggesting that the antiviral effects are 
consequence of complex formation of these alkaloids with DNA 
and/or RNA [5], [6]. These results prompted us to investigate the 
alkaloids of Leucojum vernum L., which have not been investigat­
ed earlier, and to assay the HIV-1 inhibitory activities of the al­
kaloids obtained here and earlier from Amaryllidaceae species 
[7].
Fractionation of a MeOH extract of the bulbs of L. vernum with pH 
gradient solvent-solvent partition afforded an alkaloid fraction. 
When subj ected to multiple chromatographic purifications this 
fraction yielded compounds 1 -3 . By means of NMR spectral 
analysis, compound 1 was identified as lycorine, and 2 as homo-
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Compounds 1 -3  and alkaloids isolated from other Amaryllida­
ceae species [7] were tested in vitro for HIV-1 growth inhibitory 
activity on the MT4 human T cell line. Cytotoxicity was con­
trolled in uninfected cells by means of MTT and [3H]thymidine 
incorporation assays (Table 1). The TC50 values for lycorine (1), 
haemanthidine and haemanthamine were 0.75,1.0, and 1.0 pg/ 
mL, respectively. The MT4 cells tolerated trisphaeridine, 3-epi- 
macronine, tazettine and homolycorine in higher concentrations 
(TC50 = 7.5-12.8 pg/mL). The TCID50/mL of the HIV-1 used was 
characteristically 95. The antiviral activities were determined 
by p24 antigen assay and solid-phase reverse transcriptase (RT) 
assay on the supernatants of the cells on the 7th day after infec­
tion and treatment with alkaloids and with the positive control 
AZT. For homolycorine, the MTT assay was used [12]. Trisphaeri-
Table 1 Cytotoxicity and antiretroviral effects of Amaryllidaceae alka­
loidsa
Alkaloids l s^o l s^o tlso
(pg/mL)b (pg/mL) (pg/mL)d
Lycorine (1) 0 .75 0 .4 0 .4 1.9
Hom olycorine (2) 12.8 7.3 - 1.8
Trisphaeridine 7 .50 5.0 5.0 1.5
Haem antham ine 1.00 0.8 - 1.3
Haem anthidine 1.00 not effective - -
3-Epim acronine 7 .50 not effective - -
Tazettine 7 .50 not effective - -
a All values are averages of the results of five independent experiments. 
b TC50 was determined by means of the MTT and [3H]thymidine incorporation assays. 
c Determined by p24 antigen assay, with the exception of homolycorine, where the MTT assay 
was used.
d Determined by RT assay. 
e TI50 = ID50/TC50.
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dine, lycorine and haemanthamine exhibited pronounced anti­
viral activity in the p24 test and the RT assay (examples are pres­
ented in Fig. 1 ), whereas haemanthidine, tazettine and 3-epima- 
cronine were not effective (Table 1). The MTT test revealed that 
homolycorine inhibited HIV-1 replication. The active com­
pounds displayed low therapeutic indices (TI50). None of the al­
kaloids directly inhibited the activities of AMV (avian myelo­
blastosis virus) RT and HIV RT (data not shown), suggesting 
that their targets are different. Our investigations permitted 
the conclusion that lycorine (1), homolycorine (2), haemantha­
mine and trisphaeridine inhibit HIV-1 replication effectively in 
vitro.
Materials and Methods
NMR spectra were recorded on a Bruker Avance DRX 500 spec­
trometer at 500 MHz (1H) and 125 MHz (13C). Optical rotations 
were determined with a Perkin-Elmer 341 polarimeter. Silica gel 
(Merck 5715) was used for preparative TLC, and silica gel (Kiesel­
gel 60 G, 15 pm, Merck 11677) for vacuum liquid chromatogra­
phy (VLC). The VLC column was developed under gentle vacuum 
(about 20 -  70 mm Hg), provided by a water aspirator. The degree 
of purity of the tested compounds was over 95% as documented 
by the 1H NMR spectra.
Fig. 1 Effects of Amaryllidaceae alkaloids on HIV-1 replication in vitro. 
A Reverse transcriptase test. B: p24 test.
The bulbs of Leucojum vernum were purchased from Spalax Ltd. 
(Ecser, Hungary) in September 2002. A voucher specimen (No. 
604) has been preserved in the Herbarium of the Department of 
Pharmacognosy, University of Szeged, Hungary.
The external coloured leaves of the fresh bulbs (1500 g) were re­
moved, and the bulbs were then exhaustively extracted with 
MeOH (12 L). The MeOH extract was concentrated (300 mL) and 
acidified with 2% HCl to pH 2.5. After extraction with 6x500 mL 
Et2O, the acidic solution was adjusted to pH 8.5 with concentrat­
ed NH3. The solution was extracted with 10x500 mL CHCl3 to 
yield the crude alkaloid fraction (7.2 g). The CHCl3 extract was 
fractionated by VLC using a gradient system of cyclohexane- 
CHCl3-MeOH (1:1:0, 2 5:25:1 , 2 5 :2 5 :2 , 2 5 :2 5 :3 , 2 5 :2 5 :5 , 
10: 10: 3 ,1 0 :1 0 :6 , and 1:1:1, each 150 mL) collecting fractions 
of 15 mL. Fractions 2 0 -2 2  were chromatographed by prepara­
tive TLC, first with cyclohexane-CHCl3-MeOH (50: 30: 7) (system 
A), and then with benzene-CHCl3-MeOH (7:2:1) in NH3 vapour 
(system B) with detection at UV 254 nm, affording compound 2 
(Rf : system A 0.36; system B 0.74). After preparative TLC purifica­
tion using system B, fractions 23 -2 7  furnished 3 (Rf: system A 
0.36; system B 0.56). Upon standing, fractions 3 6 -3 9  yielded ly­
corine (1) as crystalline material (m.p. 2 4 8 -2 4 9 °C, lit. [13] m.p. 
248-249 °C).
Homolycorine (2): pale-yellow crystals; m .p. 177-178°C. [a]D8 : 
+ 98 (c 0.1, EtOH); {lit. [14] m .p. 175°C; [a]D: + 85 (95% EtOH)}; 
1H-NMR (CDCl3, 500 MHz): 8 = 2.00 (3H, s, N-Me), 2.23 (1H, q, 
J  = 9.8 Hz, H-2), 2.50 (2H, m, H-3), 2.63 (3H, m, H-5, H-11b), 
2.71 (1H, brm, H-11c), 3.12 (1H, ddd, J  = 9.8, 3.3, 7.2 Hz, H-2), 
3.94 (3H, s, OCH3), 3.95 (3H, s, OCH3), 4.80 (1H, t, J  = 2.3, H-5a), 
5.50 (1H, brd, J  = 2.3, H-4), 6.96 (1H, s, H-11), 7.56 (1H, s, H-8); 
13C-NMR: identical with published data [8].
2-O-Acetyllycorine (3): pale-yellow crystals; m.p. 2 2 4 -2 2 5 °C; 
[a]D8 : +22 (c 0.1, EtOH); {lit. [10] m.p. 230-231 °C; [a]D: +20 (c 
0.2, EtOH)}; 1H-NMR (CDCl3, 500 MHz): 8 = 2.08 (3H, s, OAc), 
2.39 (1H, brq, J  = 8.9 Hz, H-5), 2.65 (2H, m, H-4), 2.71 (1H, d, 
J  = 10.4 Hz, H-11b), 2.80 (1H, d, J  = 10.4 Hz, H-11c), 3.36 (1H, 
ddd, J  = 8.9, 4.6, 4.6 Hz, H-5), 3.53 (1H, d, J  = 14.0 Hz, H-7), 4.15 
(1H, d, J  = 14.0 Hz, H-7), 4.52 (1H, s, H-1), 5.32 (1H, brs, H-2), 
5.47 (1H, brs, H-3), 5.91 and 5.94 (each 1H, each d, J  = 1.2 Hz, 
OCH2O), 6.59 (1H, s, H-8) 6.81 (1H, s, H-11); 13C-NMR (CDCl3, 
125 MHz): 8 = 21.2 (CH3CO), 28.8 (C-4), 41.9 (C-11b), 53.7 (C-5),
57.0 (C-7), 60.7 (C-11c), 69.4 (C-1), 73.8 (C-2), 101.0 (OCH2O), 
104.7 (C-11), 107.7 (C-8), 113.7 (C-3), 127.2 (C-11a), 130.1 (C-7a),
146.0 (C-3a), 146.4 (C-10), 146.7 (C-9), 170.5 (CH3CO). Copies of 
the original spectra are obtainable from the author of correspon­
dence.
Bioassays: Cells: The humanTcell line MT4 (described in ref. [15]) 
originated from cord blood lymphocytes cocultured with leukae- 
mic cells of a patient with adult T cell leukaemia. The cells were 
maintained in RPMI 1640 medium (SIGMA) supplemented with 
10% foetal bovine serum (SIGMA), 100 IU/mL of penicillin and 
100 pg/mL of streptomycin (SIGMA). For cytotoxicity and antivir­
al assays, the alkaloids were dissolved in DMSO and diluted with 
RPMI medium. The final concentration of DMSO used was be­
tween 0.05 and 1.0%. In the concentrations used, DMSO did not 
influence the cell viability.
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Virus: The clarified cell-free supernatant of HIV-1 (HTLV-IIIB)-in- 
fected MT4 cells was used as virus source. The amount of HIV-1 
(TCID50/mL) in the supernatant was determined by a virus yield 
assay [16].
MTTassay: The modified MTT [3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide] assay was performed as in ref. 
[17]. The 50% cytotoxic concentrations (TC50) were determined.
[3H]Thymidine incorporation assay: MT4 cells were incubated 
with virus and/or alkaloids. After incubation for 6 days, 5 pL of 
[3H]TTP (2 pCi/mmol) was added to the wells. The incubation 
was continued for a further 24 h, the cells were then suspended, 
and aliquots were dropped onto filter paper squares. The radio­
activities were measured in a scintillation cocktail, using a Pack­
ard 1600 CA liquid scintillation analyser.
P24 antigen assay: The INNOTEST™ HIV Antigen mAb test (IN­
NOGENETICS®) was performed on 100 pL of the supernatant of 
the treated and control cells according to the instructions of the 
manufacturer. AZT (Retrovir, Glaxo Wellcome) was used as a po­
sitive control (data shown on Fig. 1). The concentration of the 
drug was 0.27 pg/mL = 1 pM, chosen according to the literature 
data [18].
Direct reverse transcriptase (RT) assay: The modified microassay 
was carried out as described in [19].
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